Acer
is a Massachusetts-based pharmaceutical company that develops and commercializes novel therapies to treat patients with urinary tract disease... Read moreAcer
is a Massachusetts-based pharmaceutical company that develops and commercializes novel therapies to treat patients with urinary tract disease... Read more
News
Nov 21, 2023
Pharamceutical Technology
Acer: Zevra Therapeutics completes Acer acquisition in $91m deal
Nov 20, 2023
Marketscreener
Acer: Acer Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Oct 30, 2023
Owler
Acer Therapeutics, Inc.: Acer's employee count changed from 33 in Mar 2023 to 30 in Jun 2023
Oct 10, 2023
MarketScreener
Acer: ACER THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Acer Therapeutics Inc. - ACER
Sep 06, 2023
NewsFile
Press Release: Acer : SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Acer Therapeutics Inc. Buyout
Sep 04, 2023
Post Online Media
Acer: Zevra Therapeutics to acquire Acer Therapeutics for up to $91 million
Aug 31, 2023
The Business Journals
Acer: Struggling Newton biotech Acer Therapeutics scooped up by Florida firm
Aug 30, 2023
centralcharts
Press Release: Acer : Relief Therapeutics Announces New Exclusive Definitive License Agreement for OLPRUVA (ACER-001) with Acer Therapeutics
Aug 14, 2023
GlobeNewswire
Press Release: Acer : Acer Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Jun 26, 2023
LD Micro
Press Release: Acer : Acer Therapeutics Receives $1 Million Capital Infusion from Chief Executive Officer and Founder
Acer Competitors
1
2
3
4
5
6
7
8
9
10